Diversity action plans are starting to trickle into the US Food and Drug Administration’s Center for Devices and Radiological Health, a new report to Congress shows.
CDRH Report: 24 Voluntary Diversity Action Plans Filed In 2024
While the US FDA will not require diversity action plans for clinical trials for a while, some companies are already sending them in, a new FDA report to Congress shows.
